Across TCGA pan-cancer cohorts, CTBP2P5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CTBP2P5’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where CTBP2P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CTBP2P5 is over-expressed in tumor.

COAD and LUAD are the cancer types where CTBP2P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTBP2P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.024	.047	2	view →
LUAD	Female	All	+0.010	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CTBP2P5 RNA expression & survival · all CTBP2P5 data types